SPECT/CT and Tumour Imaging

Overview

Journal Eur J Nucl Med Mol Imaging

Specialties Biophysics
Nuclear Medicine
Radiology

Date 2013 Aug 31

PMID 23990144

Citations 7

Authors

Gad Abikhzer

Zohar Keidar

Affiliations

Soon will be listed here.

Abstract

Scintigraphic techniques are sensitive imaging modalities in the diagnosis and follow-up of cancer patients providing the functional and metabolic activity characteristics of the tumour. Hybrid SPECT/CT improves the diagnostic accuracy of these well-established imaging techniques by precise anatomical localization and characterization of morphological findings, differentiation between foci of physiological and pathological tracer uptake, resulting in a significant impact on patient management and more definitive interpretations. The use of SPECT/CT has been studied in a variety of applications in tumour imaging which are reviewed in this article. By combining functional and anatomical information in a single imaging session, SPECT/CT has become a one-stop cancer imaging modality.

Citing Articles

Progress of fluorescence imaging in lymph node dissection surgery for prostate and bladder cancer.

Xu M, Li P, Wei J, Yan P, Zhang Y, Guo X Front Oncol. 2024; 14:1395284.

PMID: 39429471 PMC: 11486700. DOI: 10.3389/fonc.2024.1395284.

Non-invasive molecular imaging for precision diagnosis of metastatic lymph nodes: opportunities from preclinical to clinical applications.

Cheng Z, Ma J, Yin L, Yu L, Yuan Z, Zhang B Eur J Nucl Med Mol Imaging. 2022; 50(4):1111-1133.

PMID: 36443568 DOI: 10.1007/s00259-022-06056-5.

Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge-Cell Binding Correlation.

Maspero M, Cheng X, von Kiedrowski V, Dallanoce C, Wangler B, Hubner R Pharmaceuticals (Basel). 2021; 14(10).

PMID: 34681213 PMC: 8541144. DOI: 10.3390/ph14100989.

The one-in-all diagnostic value of Tc-MDP bone scan combining with single-photon emission tomography (SPECT)/CT imaging in spinal osteoblastoma.

Ma W, Quan Z, Wang J, Li X, Li G J Orthop Surg Res. 2020; 15(1):181.

PMID: 32448317 PMC: 7245782. DOI: 10.1186/s13018-020-01653-2.

Intravenous contrast-enhanced CT can be used for CT-based attenuation correction in clinical (111)In-octreotide SPECT/CT.

Klausen T, Mortensen J, de Nijs R, Andersen F, Hojgaard L, Beyer T EJNMMI Phys. 2015; 2(1):3.

PMID: 26501805 PMC: 4545801. DOI: 10.1186/s40658-015-0108-1.

References

Aide N, Heutte N, Rame J, Rousseau E, Loiseau C, Henry-Amar M . Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer. J Clin Endocrinol Metab. 2009; 94(6):2075-84. DOI: 10.1210/jc.2008-2313. View

Schmidt D, Linke R, Uder M, Kuwert T . Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by (131)I-SPECT/CT at the first radioablation. Eur J Nucl Med Mol Imaging. 2009; 37(4):699-705. DOI: 10.1007/s00259-009-1299-2. View

Ellis R, Zhou H, Kaminsky D, Fu P, Kim E, Sodee D . Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion. Brachytherapy. 2007; 6(2):149-56. DOI: 10.1016/j.brachy.2007.01.006. View

Freitas J . Adrenal cortical and medullary imaging. Semin Nucl Med. 1995; 25(3):235-30. DOI: 10.1016/s0001-2998(95)80013-1. View

Perri M, Erba P, Volterrani D, Lazzeri E, Boni G, Grosso M . Octreo-SPECT/CT imaging for accurate detection and localization of suspected neuroendocrine tumors. Q J Nucl Med Mol Imaging. 2008; 52(4):323-33. View

Sherif A, Garske U, de la Torre M, Thorn M . Hybrid SPECT-CT: an additional technique for sentinel node detection of patients with invasive bladder cancer. Eur Urol. 2006; 50(1):83-91. DOI: 10.1016/j.eururo.2006.03.002. View

Balon H, Brown T, Goldsmith S, Silberstein E, Krenning E, Lang O . The SNM practice guideline for somatostatin receptor scintigraphy 2.0. J Nucl Med Technol. 2011; 39(4):317-24. DOI: 10.2967/jnmt.111.098277. View

Krausz Y, Bettman L, Guralnik L, Yosilevsky G, Keidar Z, Bar-Shalom R . Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J Surg. 2005; 30(1):76-83. DOI: 10.1007/s00268-005-7849-2. View

Meyer-Rochow G, Schembri G, Benn D, Sywak M, Delbridge L, Robinson B . The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma. Ann Surg Oncol. 2009; 17(2):392-400. DOI: 10.1245/s10434-009-0850-5. View

10.

Helyar V, Mohan H, Barwick T, Livieratos L, Gnanasegaran G, Clarke S . The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate. Eur J Nucl Med Mol Imaging. 2009; 37(4):706-13. DOI: 10.1007/s00259-009-1334-3. View

11.

Leijte J, Olmos R, Nieweg O, Horenblas S . Anatomical mapping of lymphatic drainage in penile carcinoma with SPECT-CT: implications for the extent of inguinal lymph node dissection. Eur Urol. 2008; 54(4):885-90. DOI: 10.1016/j.eururo.2008.04.094. View

12.

Nakamoto Y, Cohade C, Tatsumi M, Hammoud D, Wahl R . CT appearance of bone metastases detected with FDG PET as part of the same PET/CT examination. Radiology. 2005; 237(2):627-34. DOI: 10.1148/radiol.2372031994. View

13.

Schillaci O, Danieli R, Filippi L, Romano P, Cossu E, Manni C . Scintimammography with a hybrid SPECT/CT imaging system. Anticancer Res. 2007; 27(1B):557-62. View

14.

Sfakianakis G, Irvin 3rd G, Foss J, Mallin W, Georgiou M, Deriso G . Efficient parathyroidectomy guided by SPECT-MIBI and hormonal measurements. J Nucl Med. 1996; 37(5):798-804. View

15.

Papathanassiou D, Flament J, Pochart J, Patey M, Marty H, Liehn J . SPECT/CT in localization of parathyroid adenoma or hyperplasia in patients with previous neck surgery. Clin Nucl Med. 2008; 33(6):394-7. DOI: 10.1097/RLU.0b013e318170d4a5. View

16.

Zhen L, Li H, Liu X, Ge B, Yan J, Yang J . The application of SPECT/CT for preoperative planning in patients with secondary hyperparathyroidism. Nucl Med Commun. 2013; 34(5):439-44. DOI: 10.1097/MNM.0b013e32835f9447. View

17.

Sodee D, Malguria N, Faulhaber P, Resnick M, Albert J, Bakale G . Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers. Urology. 2000; 56(6):988-93. DOI: 10.1016/s0090-4295(00)00824-4. View

18.

Wagner A, Schicho K, Glaser C, Zettinig G, Yerit K, Lang S . SPECT-CT for topographic mapping of sentinel lymph nodes prior to gamma probe-guided biopsy in head and neck squamous cell carcinoma. J Craniomaxillofac Surg. 2004; 32(6):343-9. DOI: 10.1016/j.jcms.2004.05.008. View

19.

Nomori H, Ikeda K, Mori T, Kobayashi H, Iwatani K, Kawanaka K . Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007; 133(3):780-5. DOI: 10.1016/j.jtcvs.2006.10.027. View

20.

Pata G, Casella C, Besuzio S, Mittempergher F, Salerni B . Clinical appraisal of 99m technetium-sestamibi SPECT/CT compared to conventional SPECT in patients with primary hyperparathyroidism and concomitant nodular goiter. Thyroid. 2010; 20(10):1121-7. DOI: 10.1089/thy.2010.0035. View